J9042 HCPCS code: Injection, brentuximab vedotin, 1 mg
J9042 is the HCPCS Level II code for injection, brentuximab vedotin, 1 mg. In 2024 Medicare paid an average of $185.43 per service for J9042 across 259,495 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 200 per day on outpatient hospital claims. Medicare volume fell 23% from 2022 to 2024 (335,623 to 259,495 services). In 2024, about 692 clinicians billed Medicare for J9042 for 435 beneficiaries; Florida, Texas, California accounted for 52% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2013-01-01 |
| Last action effective | 2013-01-01 |
Who bills J9042 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 692 |
| Medicare beneficiaries | 435 |
| States with claims | 12 |
| Share of services in top 3 states (Florida, Texas, California) | 52% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9042, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 335,623 | 548 | $197.58 | $157.80 |
| 2023 | 312,999 | 539 | $213.23 | $170.29 |
| 2024 | 259,495 | 435 | $229.84 | $185.43 |
States with the most J9042 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 40,100 | $186.30 |
| Texas | 29,897 | $185.81 |
| California | 19,468 | $184.98 |
| Arizona | 15,700 | $185.21 |
| Illinois | 11,550 | $186.87 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 200 | CMS Policy |
| practitioner claims | 200 | CMS Policy |
What changed for J9042
- 2013-01-01: J9042 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9042?
J9042 is the HCPCS Level II code for injection, brentuximab vedotin, 1 mg. Short descriptor: "Brentuximab vedotin inj".
How much does Medicare pay for J9042?
In 2024, the average Medicare payment was $185.43 per service (average allowed $229.84).
Does Medicare cover J9042?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9042 can be billed per day?
200 on outpatient hospital claims; 200 on practitioner claims (NCCI medically unlikely edits).
Related J90 codes
- J9000 — Injection, doxorubicin hydrochloride, 10 mg
- J9003 — Leuprolide injectable (camcevi etm), 1 mg
- J9010 — Injection, alemtuzumab, 10 mg
- J9011 — Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015 — Injection, aldesleukin, per single use vial
- J9017 — Injection, arsenic trioxide, 1 mg
- J9019 — Injection, asparaginase (erwinaze), 1,000 iu
- J9020 — Injection, asparaginase, not otherwise specified, 10,000 units
- J9021 — Injection, asparaginase, recombinant, (rylaze), 0.1 mg
- J9022 — Injection, atezolizumab, 10 mg
- J9023 — Injection, avelumab, 10 mg
- J9024 — Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9042
- Watch J9042 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9042
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.